» Authors » Bruce W Eckloff

Bruce W Eckloff

Explore the profile of Bruce W Eckloff including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 1939
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Correia C, Maurer M, McDonough S, Schneider P, Ross P, Novak A, et al.
Blood Cancer J . 2023 May; 13(1):81. PMID: 37193683
How to identify follicular lymphoma (FL) patients with low disease burden but high risk for early progression is unclear. Building on a prior study demonstrating the early transformation of FLs...
2.
DiGuardo M, Davila J, Jackson R, Nair A, Fadra N, Minn K, et al.
J Mol Diagn . 2021 Feb; 23(5):555-564. PMID: 33549857
Tumor mutation burden (TMB) is an emerging biomarker of immunotherapy response. RNA sequencing in FFPE tissue samples was used for determining TMB in microsatellite-stable (MSS) and microsatellite instability-high (MSI-H) tumors...
3.
Morales-Rosado J, Goel K, Zhang L, Akerblom A, Baheti S, Black J, et al.
Cardiovasc Drugs Ther . 2020 Jul; 35(3):549-559. PMID: 32623598
Purpose: Describe CYP2C19 sequencing results in the largest series of clopidogrel-treated cases with stent thrombosis (ST), the closest clinical phenotype to clopidogrel resistance. Evaluate the impact of CYP2C19 genetic variation...
4.
Luchtel R, Zimmermann M, Hu G, Dasari S, Jiang M, Oishi N, et al.
Blood . 2019 May; 133(26):2776-2789. PMID: 31101622
Anaplastic large cell lymphomas (ALCLs) represent a relatively common group of T-cell non-Hodgkin lymphomas (T-NHLs) that are unified by similar pathologic features but demonstrate marked genetic heterogeneity. ALCLs are broadly...
5.
Preston C, Wyles S, Reyes S, Storm E, Eckloff B, Faustino R
BMC Syst Biol . 2018 Jun; 12(1):62. PMID: 29848314
Background: Atrial fibrillation is a cardiac disease driven by numerous idiopathic etiologies. NUP155 is a nuclear pore complex protein that has been identified as a clinical driver of atrial fibrillation,...
6.
Sharma A, Oishi N, Boddicker R, Hu G, Benson H, Ketterling R, et al.
Blood . 2018 Mar; 131(20):2262-2266. PMID: 29592893
No abstract available.
7.
DeRycke M, Gunawardena S, Balcom J, Pickart A, Waltman L, French A, et al.
Mol Genet Genomic Med . 2017 Sep; 5(5):553-569. PMID: 28944238
Background: Mutations in several genes predispose to colorectal cancer. Genetic testing for hereditary colorectal cancer syndromes was previously limited to single gene tests; thus, only a very limited number of...
8.
Kohli M, Ho Y, Hillman D, Van Etten J, Henzler C, Yang R, et al.
Clin Cancer Res . 2017 May; 23(16):4704-4715. PMID: 28473535
Androgen receptor (AR) variant AR-V7 is a ligand-independent transcription factor that promotes prostate cancer resistance to AR-targeted therapies. Accordingly, efforts are under way to develop strategies for monitoring and inhibiting...
9.
Sun Z, Wang L, Eckloff B, Deng B, Wang Y, Wampfler J, et al.
BMC Med Genomics . 2017 Jan; 10(1):1. PMID: 28057009
No abstract available.
10.
Boddicker R, Razidlo G, Dasari S, Zeng Y, Hu G, Knudson R, et al.
Blood . 2016 Jun; 128(9):1234-45. PMID: 27297792
Peripheral T-cell lymphomas (PTCLs) represent a heterogeneous group of T-cell malignancies that generally demonstrate aggressive clinical behavior, often are refractory to standard therapy, and remain significantly understudied. The most common...